Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.
Identifieur interne : 000636 ( Main/Exploration ); précédent : 000635; suivant : 000637Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.
Auteurs : Juliet E. Bryant [France] ; Andrew S. Azman [États-Unis, Suisse] ; Matthew J. Ferrari [États-Unis] ; Benjamin F. Arnold [États-Unis] ; Maciej F. Boni [États-Unis] ; Yap Boum [Cameroun] ; Kyla Hayford [États-Unis] ; Francisco J. Luquero [France] ; Michael J. Mina [États-Unis] ; Isabel Rodriguez-Barraquer [États-Unis] ; Joseph T. Wu [République populaire de Chine] ; Djibril Wade [Sénégal] ; Guy Vernet [République centrafricaine] ; Daniel T. Leung [États-Unis]Source :
- Science immunology [ 2470-9468 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- analyse : Anticorps antiviraux.
- diagnostic : Infections à coronavirus.
- immunologie : Betacoronavirus, Infections à coronavirus, Pneumopathie virale.
- méthodes : Techniques de laboratoire clinique.
- Humains, Pandémies, Surveillance épidémiologique.
English descriptors
- KwdEn :
- MESH :
- chemical , analysis : Antibodies, Viral.
- diagnosis : Coronavirus Infections.
- immunology : Betacoronavirus, Coronavirus Infections, Pneumonia, Viral.
- methods : Clinical Laboratory Techniques.
- Epidemiological Monitoring, Humans, Pandemics.
Abstract
Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).
DOI: 10.1126/sciimmunol.abc6347
PubMed: 32430309
Affiliations:
- Cameroun, France, République centrafricaine, République populaire de Chine, Suisse, Sénégal, États-Unis
- Auvergne-Rhône-Alpes, Californie, Maryland, Massachusetts, Pennsylvanie, Rhône-Alpes, Utah, Île-de-France
- Baltimore, Lyon, Paris, University Park (Pennsylvanie)
- Université d'État de Pennsylvanie
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.</title><author><name sortKey="Bryant, Juliet E" sort="Bryant, Juliet E" uniqKey="Bryant J" first="Juliet E" last="Bryant">Juliet E. Bryant</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Emerging Pathogens, Fondation Mérieux, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Emerging Pathogens, Fondation Mérieux, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Azman, Andrew S" sort="Azman, Andrew S" uniqKey="Azman A" first="Andrew S" last="Azman">Andrew S. Azman</name><affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore</wicri:regionArea><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Médecins Sans Frontières, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Médecins Sans Frontières, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Ferrari, Matthew J" sort="Ferrari, Matthew J" uniqKey="Ferrari M" first="Matthew J" last="Ferrari">Matthew J. Ferrari</name><affiliation wicri:level="4"><nlm:affiliation>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">University Park (Pennsylvanie)</settlement></placeName><orgName type="university">Université d'État de Pennsylvanie</orgName></affiliation></author><author><name sortKey="Arnold, Benjamin F" sort="Arnold, Benjamin F" uniqKey="Arnold B" first="Benjamin F" last="Arnold">Benjamin F. Arnold</name><affiliation wicri:level="2"><nlm:affiliation>Francis I Proctor Foundation, University of California San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Francis I Proctor Foundation, University of California San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Boni, Maciej F" sort="Boni, Maciej F" uniqKey="Boni M" first="Maciej F" last="Boni">Maciej F. Boni</name><affiliation wicri:level="4"><nlm:affiliation>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">University Park (Pennsylvanie)</settlement></placeName><orgName type="university">Université d'État de Pennsylvanie</orgName></affiliation></author><author><name sortKey="Boum, Yap" sort="Boum, Yap" uniqKey="Boum Y" first="Yap" last="Boum">Yap Boum</name><affiliation wicri:level="1"><nlm:affiliation>Epicentre, Yaounde, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Epicentre, Yaounde</wicri:regionArea><wicri:noRegion>Yaounde</wicri:noRegion></affiliation></author><author><name sortKey="Hayford, Kyla" sort="Hayford, Kyla" uniqKey="Hayford K" first="Kyla" last="Hayford">Kyla Hayford</name><affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore</wicri:regionArea><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Luquero, Francisco J" sort="Luquero, Francisco J" uniqKey="Luquero F" first="Francisco J" last="Luquero">Francisco J. Luquero</name><affiliation wicri:level="3"><nlm:affiliation>Epicentre, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Epicentre, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Mina, Michael J" sort="Mina, Michael J" uniqKey="Mina M" first="Michael J" last="Mina">Michael J. Mina</name><affiliation wicri:level="2"><nlm:affiliation>Departments of Epidemiology and of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA USA.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Departments of Epidemiology and of Immunology and Infectious Diseases, Harvard School of Public Health, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Rodriguez Barraquer, Isabel" sort="Rodriguez Barraquer, Isabel" uniqKey="Rodriguez Barraquer I" first="Isabel" last="Rodriguez-Barraquer">Isabel Rodriguez-Barraquer</name><affiliation wicri:level="2"><nlm:affiliation>School of Medicine, University of California San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>School of Medicine, University of California San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Wu, Joseph T" sort="Wu, Joseph T" uniqKey="Wu J" first="Joseph T" last="Wu">Joseph T. Wu</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>WHO Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR</wicri:regionArea><wicri:noRegion>Hong Kong SAR</wicri:noRegion></affiliation></author><author><name sortKey="Wade, Djibril" sort="Wade, Djibril" uniqKey="Wade D" first="Djibril" last="Wade">Djibril Wade</name><affiliation wicri:level="1"><nlm:affiliation>IRESSEF (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation), Dakar, Senegal.</nlm:affiliation><country xml:lang="fr">Sénégal</country><wicri:regionArea>IRESSEF (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation), Dakar</wicri:regionArea><wicri:noRegion>Dakar</wicri:noRegion></affiliation></author><author><name sortKey="Vernet, Guy" sort="Vernet, Guy" uniqKey="Vernet G" first="Guy" last="Vernet">Guy Vernet</name><affiliation wicri:level="1"><nlm:affiliation>Institut Pasteur de Bangui, Bangui, Central African Republic.</nlm:affiliation><country xml:lang="fr">République centrafricaine</country><wicri:regionArea>Institut Pasteur de Bangui, Bangui</wicri:regionArea><wicri:noRegion>Bangui</wicri:noRegion></affiliation></author><author><name sortKey="Leung, Daniel T" sort="Leung, Daniel T" uniqKey="Leung D" first="Daniel T" last="Leung">Daniel T. Leung</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USA daniel.leung@utah.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT</wicri:regionArea><placeName><region type="state">Utah</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32430309</idno><idno type="pmid">32430309</idno><idno type="doi">10.1126/sciimmunol.abc6347</idno><idno type="wicri:Area/Main/Corpus">001198</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001198</idno><idno type="wicri:Area/Main/Curation">001198</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001198</idno><idno type="wicri:Area/Main/Exploration">001198</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.</title><author><name sortKey="Bryant, Juliet E" sort="Bryant, Juliet E" uniqKey="Bryant J" first="Juliet E" last="Bryant">Juliet E. Bryant</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Emerging Pathogens, Fondation Mérieux, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Emerging Pathogens, Fondation Mérieux, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Azman, Andrew S" sort="Azman, Andrew S" uniqKey="Azman A" first="Andrew S" last="Azman">Andrew S. Azman</name><affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore</wicri:regionArea><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Médecins Sans Frontières, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Médecins Sans Frontières, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Ferrari, Matthew J" sort="Ferrari, Matthew J" uniqKey="Ferrari M" first="Matthew J" last="Ferrari">Matthew J. Ferrari</name><affiliation wicri:level="4"><nlm:affiliation>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">University Park (Pennsylvanie)</settlement></placeName><orgName type="university">Université d'État de Pennsylvanie</orgName></affiliation></author><author><name sortKey="Arnold, Benjamin F" sort="Arnold, Benjamin F" uniqKey="Arnold B" first="Benjamin F" last="Arnold">Benjamin F. Arnold</name><affiliation wicri:level="2"><nlm:affiliation>Francis I Proctor Foundation, University of California San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Francis I Proctor Foundation, University of California San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Boni, Maciej F" sort="Boni, Maciej F" uniqKey="Boni M" first="Maciej F" last="Boni">Maciej F. Boni</name><affiliation wicri:level="4"><nlm:affiliation>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">University Park (Pennsylvanie)</settlement></placeName><orgName type="university">Université d'État de Pennsylvanie</orgName></affiliation></author><author><name sortKey="Boum, Yap" sort="Boum, Yap" uniqKey="Boum Y" first="Yap" last="Boum">Yap Boum</name><affiliation wicri:level="1"><nlm:affiliation>Epicentre, Yaounde, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Epicentre, Yaounde</wicri:regionArea><wicri:noRegion>Yaounde</wicri:noRegion></affiliation></author><author><name sortKey="Hayford, Kyla" sort="Hayford, Kyla" uniqKey="Hayford K" first="Kyla" last="Hayford">Kyla Hayford</name><affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore</wicri:regionArea><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Luquero, Francisco J" sort="Luquero, Francisco J" uniqKey="Luquero F" first="Francisco J" last="Luquero">Francisco J. Luquero</name><affiliation wicri:level="3"><nlm:affiliation>Epicentre, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Epicentre, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Mina, Michael J" sort="Mina, Michael J" uniqKey="Mina M" first="Michael J" last="Mina">Michael J. Mina</name><affiliation wicri:level="2"><nlm:affiliation>Departments of Epidemiology and of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA USA.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Departments of Epidemiology and of Immunology and Infectious Diseases, Harvard School of Public Health, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Rodriguez Barraquer, Isabel" sort="Rodriguez Barraquer, Isabel" uniqKey="Rodriguez Barraquer I" first="Isabel" last="Rodriguez-Barraquer">Isabel Rodriguez-Barraquer</name><affiliation wicri:level="2"><nlm:affiliation>School of Medicine, University of California San Francisco, CA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>School of Medicine, University of California San Francisco, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Wu, Joseph T" sort="Wu, Joseph T" uniqKey="Wu J" first="Joseph T" last="Wu">Joseph T. Wu</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>WHO Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR</wicri:regionArea><wicri:noRegion>Hong Kong SAR</wicri:noRegion></affiliation></author><author><name sortKey="Wade, Djibril" sort="Wade, Djibril" uniqKey="Wade D" first="Djibril" last="Wade">Djibril Wade</name><affiliation wicri:level="1"><nlm:affiliation>IRESSEF (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation), Dakar, Senegal.</nlm:affiliation><country xml:lang="fr">Sénégal</country><wicri:regionArea>IRESSEF (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation), Dakar</wicri:regionArea><wicri:noRegion>Dakar</wicri:noRegion></affiliation></author><author><name sortKey="Vernet, Guy" sort="Vernet, Guy" uniqKey="Vernet G" first="Guy" last="Vernet">Guy Vernet</name><affiliation wicri:level="1"><nlm:affiliation>Institut Pasteur de Bangui, Bangui, Central African Republic.</nlm:affiliation><country xml:lang="fr">République centrafricaine</country><wicri:regionArea>Institut Pasteur de Bangui, Bangui</wicri:regionArea><wicri:noRegion>Bangui</wicri:noRegion></affiliation></author><author><name sortKey="Leung, Daniel T" sort="Leung, Daniel T" uniqKey="Leung D" first="Daniel T" last="Leung">Daniel T. Leung</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USA daniel.leung@utah.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT</wicri:regionArea><placeName><region type="state">Utah</region></placeName></affiliation></author></analytic><series><title level="j">Science immunology</title><idno type="eISSN">2470-9468</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (analysis)</term><term>Betacoronavirus (immunology)</term><term>Clinical Laboratory Techniques (methods)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (immunology)</term><term>Epidemiological Monitoring (MeSH)</term><term>Humans (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (analyse)</term><term>Betacoronavirus (immunologie)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (immunologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (immunologie)</term><term>Surveillance épidémiologique (MeSH)</term><term>Techniques de laboratoire clinique (méthodes)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Betacoronavirus</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Betacoronavirus</term><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Clinical Laboratory Techniques</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Techniques de laboratoire clinique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Epidemiological Monitoring</term><term>Humans</term><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Pandémies</term><term>Surveillance épidémiologique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32430309</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2470-9468</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>47</Issue><PubDate><Year>2020</Year><Month>05</Month><Day>19</Day></PubDate></JournalIssue><Title>Science immunology</Title><ISOAbbreviation>Sci Immunol</ISOAbbreviation></Journal><ArticleTitle>Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eabc6347</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciimmunol.abc6347</ELocationID><Abstract><AbstractText>Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).</AbstractText><CopyrightInformation>Copyright © 2020, American Association for the Advancement of Science.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bryant</LastName><ForeName>Juliet E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Laboratory of Emerging Pathogens, Fondation Mérieux, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azman</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Médecins Sans Frontières, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Benjamin F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Francis I Proctor Foundation, University of California San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boni</LastName><ForeName>Maciej F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boum</LastName><ForeName>Yap</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Epicentre, Yaounde, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayford</LastName><ForeName>Kyla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luquero</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Epicentre, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mina</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Departments of Epidemiology and of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Barraquer</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>School of Medicine, University of California San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Joseph T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>WHO Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wade</LastName><ForeName>Djibril</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IRESSEF (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation), Dakar, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernet</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Bangui, Bangui, Central African Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Daniel T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USA daniel.leung@utah.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Immunol</MedlineTA><NlmUniqueID>101688624</NlmUniqueID><ISSNLinking>2470-9468</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Protocol" UI="C000657964">COVID-19 diagnostic testing</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32430309</ArticleId><ArticleId IdType="pii">5/47/eabc6347</ArticleId><ArticleId IdType="doi">10.1126/sciimmunol.abc6347</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Cameroun</li><li>France</li><li>République centrafricaine</li><li>République populaire de Chine</li><li>Suisse</li><li>Sénégal</li><li>États-Unis</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Californie</li><li>Maryland</li><li>Massachusetts</li><li>Pennsylvanie</li><li>Rhône-Alpes</li><li>Utah</li><li>Île-de-France</li></region><settlement><li>Baltimore</li><li>Lyon</li><li>Paris</li><li>University Park (Pennsylvanie)</li></settlement><orgName><li>Université d'État de Pennsylvanie</li></orgName></list><tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Bryant, Juliet E" sort="Bryant, Juliet E" uniqKey="Bryant J" first="Juliet E" last="Bryant">Juliet E. Bryant</name></region><name sortKey="Luquero, Francisco J" sort="Luquero, Francisco J" uniqKey="Luquero F" first="Francisco J" last="Luquero">Francisco J. Luquero</name></country><country name="États-Unis"><region name="Maryland"><name sortKey="Azman, Andrew S" sort="Azman, Andrew S" uniqKey="Azman A" first="Andrew S" last="Azman">Andrew S. Azman</name></region><name sortKey="Arnold, Benjamin F" sort="Arnold, Benjamin F" uniqKey="Arnold B" first="Benjamin F" last="Arnold">Benjamin F. Arnold</name><name sortKey="Boni, Maciej F" sort="Boni, Maciej F" uniqKey="Boni M" first="Maciej F" last="Boni">Maciej F. Boni</name><name sortKey="Ferrari, Matthew J" sort="Ferrari, Matthew J" uniqKey="Ferrari M" first="Matthew J" last="Ferrari">Matthew J. Ferrari</name><name sortKey="Hayford, Kyla" sort="Hayford, Kyla" uniqKey="Hayford K" first="Kyla" last="Hayford">Kyla Hayford</name><name sortKey="Leung, Daniel T" sort="Leung, Daniel T" uniqKey="Leung D" first="Daniel T" last="Leung">Daniel T. Leung</name><name sortKey="Mina, Michael J" sort="Mina, Michael J" uniqKey="Mina M" first="Michael J" last="Mina">Michael J. Mina</name><name sortKey="Rodriguez Barraquer, Isabel" sort="Rodriguez Barraquer, Isabel" uniqKey="Rodriguez Barraquer I" first="Isabel" last="Rodriguez-Barraquer">Isabel Rodriguez-Barraquer</name></country><country name="Suisse"><noRegion><name sortKey="Azman, Andrew S" sort="Azman, Andrew S" uniqKey="Azman A" first="Andrew S" last="Azman">Andrew S. Azman</name></noRegion></country><country name="Cameroun"><noRegion><name sortKey="Boum, Yap" sort="Boum, Yap" uniqKey="Boum Y" first="Yap" last="Boum">Yap Boum</name></noRegion></country><country name="République populaire de Chine"><noRegion><name sortKey="Wu, Joseph T" sort="Wu, Joseph T" uniqKey="Wu J" first="Joseph T" last="Wu">Joseph T. Wu</name></noRegion></country><country name="Sénégal"><noRegion><name sortKey="Wade, Djibril" sort="Wade, Djibril" uniqKey="Wade D" first="Djibril" last="Wade">Djibril Wade</name></noRegion></country><country name="République centrafricaine"><noRegion><name sortKey="Vernet, Guy" sort="Vernet, Guy" uniqKey="Vernet G" first="Guy" last="Vernet">Guy Vernet</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000636 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000636 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32430309
|texte= Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32430309" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |